All health and safety claims regarding electronic cigarettes relative to combustible tobacco in advertising and media should cease
These measurements are not exact and the manufacturer may vary slightly (between 1 and 3 cm) from one batch to another
Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products Peck MJ, Sanders EB, Scherer G, Luedicke F, Weitkunat R Biomarkers, Volume 23(3), doi: 10.1080/1354750X.2017.1419284 Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review Scherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002 Determination of flavors and their metabolites in e-liquids and biological fluids - Identification of biomarkers of exposure to prominent e-cigarette flavors Riedel K, Pluym N, Scherer G, Scherer M CORESTA SSPT 2015, Jeju, South Korea Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany Showcases for successful European legislation Therese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 Untargeted metabolomic profiling in saliva of smokers and nonsmokers by a validated GC-TOF-MS method Mueller DC, Piller M, Niessner R, Scherer M, Scherer G Journal of Proteome Research, Volume 13, doi: 10.1021/pr401099r Urinary cotinine and exposure to passive smoke in children and adolescents in Germany Human biomonitoring results of the German Environmental Survey 20142017 (GerES V) Domenica Hahn, Maria Schmied-Tobies, Enrico Rucic, Nikola Pluym, Max Scherer, Malgorzata Debiak, Aline Murawski, Marike Kolossa-Gehring Environmental Research doi.org/10.1016/j.envres.2022.114320 The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in Germany Therese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers Kavvadias D, Scherer G, Cheung F, Errington G, Shepperd J, McEwan M Biomarkers, Volume 14, doi: 10.3109/13547500903242883 Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine Kavvadias D, Scherer G, Urban M, Cheung F, Errington G, Shepperd J, McEwan M Journal of Chromatography B, Volume 877, doi: 10.1016/j.jchromb.2009.03.009 Assessment of the Exposure to NNN in the Plasma of Smokeless Tobacco Users Pluym N, Scherer G, Edmiston J, Jin X, Sarkar M, Scherer M Chemical Research in Toxicology, doi:10.1021/acs.chemrestox.1c00431 NNN a suitable biomarker of exposure from smoke and new nicotine delivery products
I called Alaskas Tobacco Quit Line two times and it was just nice talking to somebody that was supportive
